The TLR5 Agonist Flagellin Shapes Phenotypical and Functional Activation of Lung Mucosal Antigen Presenting Cells in Neonatal Mice.

Frontiers in Immunology
Pankaj SharmaDavid J. Dowling

Abstract

Intranasal mucosal vaccines are an attractive approach to induce protective mucosal immune responses. Activation of lung antigen presenting cells (APCs), a phenotypically and functionally heterogeneous cell population located at distinct mucosal sites, may be key to the immunogenicity of such vaccines. Understanding responsiveness of newborn lung APCs to adjuvants may the inform design of efficacious intranasal vaccines for early life, when most infections occur. Here, we characterized and phenotyped APCs from neonatal (7 days of life) and adult (6-8 weeks of age) mice. Neonatal mice demonstrated a relatively high abundance of alveolar macrophages (AMs), with lower percentages of plasmacytoid dendritic cells (pDCs), CD103+ (cDC1), and CD11b+ (cDC2) DCs. Furthermore, neonatal CD103+ and CD11b+ DC subsets demonstrated a significantly lower expression of maturation markers (CD40, CD80, and CD86) as compared to adult mice. Upon stimulation of lung APC subsets with a panel of pattern recognition receptor (PRR) agonists, including those engaging TLRs or STING, CD11c+ enriched cells from neonatal and adult mice lungs demonstrated distinct maturation profiles. Of the agonists tested, the TLR5 ligand, flagellin, was most effective at ac...Continue Reading

References

Apr 9, 2001·Clinical Microbiology Reviews·P L OgraR C Welliver
Mar 29, 2003·Blood·Cheng-Ming SunRichard Lo-Man
Feb 24, 2006·Nature Reviews. Immunology·Marian R Neutra, Pamela A Kozlowski
Aug 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hongwei WangJürgen Schwarze
Dec 26, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mark McCarron, Denis J Reen
Jan 21, 2009·The Journal of Experimental Medicine·Heung Kyu LeeAkiko Iwasaki
Jul 17, 2009·Immunology·Maureen L DrakesThomas G Blanchard
Nov 20, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Igor M Belyakov, Jeffrey D Ahlers
Jun 23, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Laurye Van MaeleJean-Claude Sirard
Jul 21, 2010·Infection and Immunity·Natalia MuñozJosé A Chabalgoity
Apr 26, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·John T BatesSteven B Mizel
Nov 5, 2011·Nature Reviews. Immunology·Rino RappuoliEnnio De Gregorio
May 15, 2012·Current Opinion in Immunology·Jan Holmgren, Ann-Mari Svennerholm
Jul 26, 2012·Nature Reviews. Immunology·Nils Lycke
Dec 19, 2012·Immunity·Sun-Young ChangHans-Christian Reinecker
Jul 5, 2013·Journal of Leukocyte Biology·Wei Hu, Chandrashekhar Pasare
Sep 26, 2013·Mucosal Immunology·L Van MaeleJ-C Sirard
Dec 7, 2013·Nature Medicine·Steven G ReedChristopher B Fox
Jun 2, 2014·Trends in Immunology·David J Dowling, Ofer Levy
Jun 26, 2014·Expert Opinion on Drug Delivery·Peggy RieseCarlos A Guzmán
Jul 19, 2014·Nature Reviews. Immunology·Martin GuilliamsSimon Yona
Aug 13, 2014·Trends in Immunology·Yanet ValdezB Brett Finlay
Nov 11, 2014·Nature Medicine·Menna R ClatworthyRonald N Germain
Sep 10, 2015·The Pediatric Infectious Disease Journal·David J Dowling, Ofer Levy
Feb 9, 2016·Current Opinion in Allergy and Clinical Immunology·Avraham Beigelman, Leonard B Bacharier
Feb 11, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Akhilesh Kumar ShakyaHarvinder Singh Gill
Apr 30, 2016·Science·Thomas GensollenRichard S Blumberg
Jun 29, 2016·Expert Opinion on Drug Delivery·Lungile Nomcebo ThwalaNoémi Stefania Csaba
Jun 30, 2016·Perspectives in Public Health·David J Dowling
Sep 22, 2016·Mucosal Immunology·N TorowE S Gollwitzer
Oct 27, 2016·Frontiers in Immunology·Annalisa CiabattiniDonata Medaglini
Dec 18, 2016·Current Opinion in Virology·Pamela C RosatoDavid Masopust
Jan 11, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Natalia Torow, Mathias W Hornef
Feb 9, 2017·Clinical and Experimental Vaccine Research·Sae-Hae Kim, Yong-Suk Jang
Apr 10, 2017·The Journal of Allergy and Clinical Immunology·Thomas Gensollen, Richard S Blumberg

❮ Previous
Next ❯

Methods Mentioned

BETA
magnetic
flow cytometry

Software Mentioned

GraphPad
BD
Excel
Prism
Flowjo
Treestar

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.